Raised melanoma risk from biologics 'cannot be ruled out'

Authors of systematic review and meta-analysis say larger studies are needed to clarify the issue

Pooled evidence from cohort studies of patients treated with biologic therapy for rheumatoid arthritis, IBD and psoriasis does not show a statistically significant increased risk of melanoma, a study shows.